News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,474 Results
Type
Article (4252)
Company Profile (26)
Press Release (178196)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (74340)
Career Advice (81)
Deals (12426)
Drug Delivery (10)
Drug Development (22857)
Employer Resources (9)
FDA (3973)
Job Trends (4396)
News (111430)
Policy (7578)
Tag
Academia (371)
Academic (1)
Accelerated approval (1)
Adcomms (2)
Allergies (33)
Alliances (8835)
ALS (16)
Alzheimer's disease (342)
Antibody-drug conjugate (ADC) (21)
Approvals (4014)
Artificial intelligence (31)
Autoimmune disease (5)
Automation (3)
Bankruptcy (98)
Best Places to Work (4023)
Biosimilars (16)
Biotechnology (19)
Bladder cancer (28)
Brain cancer (4)
Breast cancer (113)
Cancer (724)
Cardiovascular disease (61)
Career advice (66)
Career pathing (4)
CAR-T (31)
Cell therapy (95)
Cervical cancer (6)
Clinical research (19879)
Collaboration (172)
Company closure (1)
Compensation (92)
Complete response letters (4)
COVID-19 (497)
CRISPR (13)
C-suite (46)
Cystic fibrosis (21)
Data (919)
Depression (12)
Diabetes (79)
Diagnostics (1804)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (14)
Drug pricing (12)
Drug shortages (1)
Duchenne muscular dystrophy (27)
Earnings (57416)
Editorial (3)
Employer branding (1)
Employer resources (7)
Events (24499)
Executive appointments (143)
FDA (4445)
Frontotemporal dementia (3)
Funding (141)
Gene editing (29)
Generative AI (2)
Gene therapy (98)
GLP-1 (149)
Government (671)
Guidances (129)
Healthcare (5075)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (27)
Indications (10)
Infectious disease (532)
Inflammatory bowel disease (54)
Inflation Reduction Act (2)
Influenza (13)
Intellectual property (32)
Interviews (9)
IPO (7630)
IRA (3)
Job creations (607)
Job search strategy (59)
Kidney cancer (5)
Labor market (9)
Layoffs (105)
Leadership (1)
Legal (1476)
Liver cancer (19)
Lung cancer (118)
Lymphoma (63)
Machine learning (1)
Management (2)
Manufacturing (55)
MASH (33)
Medical device (4095)
Medtech (4096)
Mergers & acquisitions (5004)
Metabolic disorders (168)
Multiple sclerosis (44)
NASH (8)
Neurodegenerative disease (28)
Neuropsychiatric disorders (4)
Neuroscience (502)
NextGen: Class of 2025 (1233)
Non-profit (666)
Now hiring (3)
Obesity (57)
Opinion (21)
Ovarian cancer (28)
Pain (27)
Pancreatic cancer (22)
Parkinson's disease (43)
Partnered (3)
Patents (69)
Patient recruitment (32)
Peanut (24)
People (8933)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase I (5372)
Phase II (8382)
Phase III (7747)
Pipeline (899)
Policy (12)
Postmarket research (699)
Preclinical (1739)
Press Release (21)
Prostate cancer (26)
Psychedelics (1)
Radiopharmaceuticals (62)
Rare diseases (89)
Real estate (814)
Recruiting (5)
Regulatory (5985)
Reports (9)
Research institute (299)
Resumes & cover letters (8)
Rett syndrome (4)
RNA editing (1)
RSV (13)
Schizophrenia (22)
Series A (11)
Series B (9)
Service/supplier (1)
Sickle cell disease (23)
Special edition (6)
Spinal muscular atrophy (44)
Startups (388)
Stomach cancer (4)
Supply chain (5)
Tariffs (4)
The Weekly (2)
Vaccines (138)
Venture capitalists (6)
Weight loss (33)
Women's health (7)
Worklife (3)
Date
Last 7 days (471)
Last 30 days (1166)
Last 365 days (11335)
2025 (4206)
2024 (12436)
2023 (14249)
2022 (15023)
2021 (15442)
2020 (14629)
2019 (11549)
2018 (8555)
2017 (9851)
2016 (7839)
2015 (9547)
2014 (7173)
2013 (5389)
2012 (5767)
2011 (6151)
2010 (5754)
Location
Africa (93)
Alabama (23)
Arizona (51)
Arkansas (2)
Asia (10403)
Australia (1075)
California (2175)
Canada (640)
China (120)
Colorado (107)
Connecticut (98)
Delaware (72)
Europe (23460)
Florida (308)
Georgia (108)
Idaho (12)
Illinois (136)
India (6)
Indiana (179)
Iowa (4)
Japan (65)
Kansas (24)
Kentucky (5)
Louisiana (4)
Maine (37)
Maryland (315)
Massachusetts (1552)
Michigan (68)
Minnesota (123)
Missouri (37)
Montana (10)
Nebraska (3)
Nevada (36)
New Hampshire (21)
New Jersey (830)
New Mexico (3)
New York (668)
North Carolina (334)
North Dakota (1)
Northern California (952)
Ohio (44)
Oregon (6)
Pennsylvania (508)
Puerto Rico (4)
Rhode Island (9)
South America (195)
South Carolina (10)
Southern California (873)
Tennessee (28)
Texas (426)
United States (8509)
Utah (71)
Virginia (59)
Washington D.C. (17)
Washington State (214)
Wisconsin (5)
182,474 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SIGA Reports Financial Results for Three Months Ended March 31, 2025
May 9, 2025
·
10 min read
Press Releases
PureTech Announces Annual Results for Year Ended December 31, 2024
April 30, 2025
·
19 min read
Press Releases
Organon Reports Results for the First Quarter Ended March 31, 2025
May 1, 2025
·
19 min read
Press Releases
Santhera Full Year Results for the Year Ended 31 December 2024
April 29, 2025
·
30 min read
Press Releases
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
May 7, 2025
·
29 min read
Press Releases
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
May 8, 2025
·
15 min read
Press Releases
Preliminary results for the year ended 31 December 2024
April 10, 2025
·
91 min read
Press Releases
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2025
May 7, 2025
·
25 min read
Press Releases
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025
May 8, 2025
·
6 min read
Press Releases
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025
May 8, 2025
·
6 min read
1 of 18,248
Next
